Optinose Announces Proposed Public Offering of Common Stock
13 août 2020 16h26 HE
|
Optinose, Inc.
YARDLEY, Pa., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, today announced the...
Optinose Reports Second Quarter 2020 Financial Results and Recent Operational Highlights
04 août 2020 07h00 HE
|
Optinose, Inc.
Company reports second quarter 2020 XHANCE net revenue of $10.3 million Second quarter 2020 XHANCE prescriptions increased 84% from second quarter 2019 Conference call and webcast to be held today...
Optinose Announces Reporting Date for Second Quarter 2020 Financial Results
30 juil. 2020 16h01 HE
|
Optinose, Inc.
YARDLEY, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose names Catherine E. Owen as Director
29 juil. 2020 16h01 HE
|
Optinose, Inc.
YARDLEY, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose Announces XHANCE Co-Promotion Agreement with Kaléo
08 juil. 2020 16h15 HE
|
Optinose, Inc.
YARDLEY, Pa., July 08, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose Announces Anti-COVID-19 Product Candidate
30 juin 2020 08h00 HE
|
Optinose, Inc.
YARDLEY, Pa., June 30, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
22 juin 2020 08h30 HE
|
Optinose, Inc.
YARDLEY, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose Named a 2020 Best Place to Work by Philadelphia Business Journal
19 juin 2020 10h00 HE
|
Optinose, Inc.
YARDLEY, Pa., June 19, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose to Host its Annual Meeting of Stockholders in Virtual Format
27 mai 2020 16h30 HE
|
Optinose, Inc.
YARDLEY, Pa., May 27, 2020 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN) today announced that due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and...
Optinose to Present at the 2020 Jefferies Virtual Healthcare Conference
26 mai 2020 09h00 HE
|
Optinose, Inc.
YARDLEY, Penn., May 26, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...